why choose us

First received: September 10, 2023

Clinical Trial: Sonodynamic Therapy in Patients With Recurrent GBM

Study Status: Completed

Recruit Status: RECRUITING

Condition: Recurrent Glioblastoma

Study Type: INTERVENTIONAL


Official Title: Pilot Study of Sonodynamic Therapy With 5-ALA for the Treatment of Recurrent Glioblastoma Using Neuronavigation-Guided Low-Intensity Focused Ultrasound

Brief Summary: Patients diagnosed with glioblastoma (GBM) are faced with limited treatment options.This pilot study will evaluate the safety and feasibility of combining an investigational drug called 5-ALA with neuronavigation-guided low-intensity focused ultrasound (LIFU) for patients who have recurrent GBM.Focused ultrasound (FUS) can be used to non-invasively destroy tumor tissue while preserving normal tissue.When FUS is combined with 5-ALA, this combinatorial approach is called sonodynamic therapy (SDT), and this…

Read more